OVERCOMING RESISTANCE TO TRASTUZUMAB IN HER2-AMPLIFIED BREAST CANCERS

$324,000FY2010Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →